[go: up one dir, main page]

UY30851A1 - Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos - Google Patents

Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos

Info

Publication number
UY30851A1
UY30851A1 UY30851A UY30851A UY30851A1 UY 30851 A1 UY30851 A1 UY 30851A1 UY 30851 A UY30851 A UY 30851A UY 30851 A UY30851 A UY 30851A UY 30851 A1 UY30851 A1 UY 30851A1
Authority
UY
Uruguay
Prior art keywords
amino
synthesis
tetrahidrofuran
carboxilico
medications
Prior art date
Application number
UY30851A
Other languages
English (en)
Inventor
Nathan K Yee
Yibo Xu
Wenjung Tang
Chris H Senanayake
Rolalnd Pfau
Burkhard Matthes
Dhileepkumar Krishnamurthy
Zhengxu Han
Dr Annette Mario Schuler Metz
Dr Wolfgang Wienen
Dr Henning Priepke
Dr Herbert Nar
Dr Kai Gerlach
Dr Peter Sieger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY30851A1 publication Critical patent/UY30851A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Proceso para la fabricacion de amidas del ácido 3-amino-tetrahidrofurano-3-carboxílico sustituidas de formula general (I) y sus precursores con alta pureza optica a los precursores de la síntesis de amidas del ácido 3-amino-tetrahidrofurano-3-carboxílico sustituidas de la formula general (I) con alta pureza optica, y a los tautomeros, enantiomeros, diasteromeros, mezclas y sales de amidas de ácido 3-amino-tetrahidrofurano-3-carboxílico sustituidas de formula general (I) con alta pureza optica, particularmente las sales fisiologicamente aceptables de las mismas con ácidos o bases inorgánicas, que tienen propiedades valiosas.
UY30851A 2006-12-31 2007-12-28 Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos UY30851A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88293706P 2006-12-31 2006-12-31

Publications (1)

Publication Number Publication Date
UY30851A1 true UY30851A1 (es) 2008-07-31

Family

ID=39253961

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30851A UY30851A1 (es) 2006-12-31 2007-12-28 Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos

Country Status (23)

Country Link
US (2) US20100317848A1 (es)
EP (1) EP2114909A2 (es)
JP (1) JP2010514729A (es)
KR (1) KR20090097208A (es)
CN (1) CN101573346B (es)
AR (1) AR064708A1 (es)
AU (1) AU2007341335A1 (es)
BR (1) BRPI0720748A2 (es)
CA (1) CA2674168A1 (es)
CL (1) CL2007003875A1 (es)
EA (1) EA200900797A1 (es)
EC (1) ECSP099406A (es)
MA (1) MA31116B1 (es)
MY (1) MY148769A (es)
NO (1) NO20091782L (es)
NZ (1) NZ578715A (es)
PE (1) PE20081834A1 (es)
TN (1) TN2009000276A1 (es)
TW (1) TW200846345A (es)
UA (1) UA96973C2 (es)
UY (1) UY30851A1 (es)
WO (1) WO2008080891A2 (es)
ZA (1) ZA200902451B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070171A1 (es) 2005-06-30 2007-03-08 Boehringer Ingelheim Int GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa
JP5524852B2 (ja) * 2007-11-15 2014-06-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミド、それらの製造及び医薬品としての使用
EP2497489A1 (en) * 2011-03-09 2012-09-12 CSL Behring GmbH Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
CA2829037C (en) * 2011-03-09 2022-05-17 Csl Behring Gmbh Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
WO2014060575A2 (en) * 2012-10-19 2014-04-24 Medichem S.A. Process for the enantioselective synthesis of a tetrahydrobenzazepine compound
RU2520134C1 (ru) * 2013-02-27 2014-06-20 Общество с ограниченной ответственностью "Авионко" (ООО "Авионко") Замещенные (r)-3-(4-метилкарбамоил-3-фторфениламино)-тетрагидро-фуран-3-енкарбоновые кислоты и их эфиры, способ их получения и применения
WO2014135694A1 (en) 2013-03-08 2014-09-12 Csl Behring Ag Treatment and prevention of remote ischemia-reperfusion injury
WO2014187768A1 (en) * 2013-05-20 2014-11-27 Lek Pharmaceuticals D.D. Novel synthetic processes to 8-chloro-3-benzo[d]azepine via friedel-crafts alkylation of olefin
CN104530029B (zh) * 2014-12-09 2017-04-12 广东东阳光药业有限公司 作为Xa因子抑制剂的杂环化合物及其使用方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005243535A1 (en) * 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Novel substituted thiophenecarboxamides, their production and their use as medicaments
CA2565186A1 (en) * 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
JP2007537179A (ja) * 2004-05-13 2007-12-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換チオフェン−２−カルボン酸アミド、その製法及び薬物としての使用
DE102004047840A1 (de) * 2004-09-29 2006-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
PE20070171A1 (es) * 2005-06-30 2007-03-08 Boehringer Ingelheim Int GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa

Also Published As

Publication number Publication date
WO2008080891A3 (en) 2008-10-02
CN101573346A (zh) 2009-11-04
PE20081834A1 (es) 2009-01-16
MA31116B1 (fr) 2010-01-04
WO2008080891A2 (en) 2008-07-10
MY148769A (en) 2013-05-31
NO20091782L (no) 2009-06-10
ZA200902451B (en) 2010-05-26
ECSP099406A (es) 2009-07-31
TW200846345A (en) 2008-12-01
NZ578715A (en) 2012-06-29
CA2674168A1 (en) 2008-07-10
KR20090097208A (ko) 2009-09-15
CL2007003875A1 (es) 2008-04-18
EA200900797A1 (ru) 2009-12-30
BRPI0720748A2 (pt) 2015-05-19
UA96973C2 (ru) 2011-12-26
AU2007341335A1 (en) 2008-07-10
TN2009000276A1 (fr) 2010-10-18
CN101573346B (zh) 2013-01-09
AR064708A1 (es) 2009-04-22
JP2010514729A (ja) 2010-05-06
US20130005962A1 (en) 2013-01-03
US20100317848A1 (en) 2010-12-16
EP2114909A2 (en) 2009-11-11

Similar Documents

Publication Publication Date Title
UY30851A1 (es) Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
MX2010003224A (es) Derivados de biaril sulfonamida.
AR047917A1 (es) Derivados de 4-benzimidazol-2-il-piridazin-3-ona, preparacion de los mismos, y su empleo en medicamentos
UY33501A (es) Derivados de acil sulfonamida y sus sales farmacéuticamente aceptables para uso en medicina
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
ECSP10010178A (es) Derivados bis-(sulfonilamino) en terapia 066
UY30267A1 (es) Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones
UY30859A1 (es) Nuevos derivados de 2-anilino-4-heteroarilpirimidinas , su preparacion, como medicamentos, composiciones farmacéuticas y especialmente como inhibidores de ikk
NI200800227A (es) Acidos 1,3-dioxano carboxilicos
CR10027A (es) Nuevos derivados de pirrol fusionado
ECSP077271A (es) Derivados de pirimidina
UY30857A1 (es) Nuevos derivados de n,n'-2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y especialmente como inhibidores de ikk
UY32379A (es) Derivados de n-heteroarilo sulfonammida sustituidos, sales, solvatos o tautómero farmacéuticamente aceptables, procesos de preparación, intermedios, composicones conteniéndolos y aplicaciones.
UY32848A (es) Compuestos heterocíclicos de oxima
ECSP066898A (es) Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento
AR077415A2 (es) Derivados de oxindol sustituido , medicamentos que los comprenden y uso de los mismos
MX2012004311A (es) Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes.
UY30856A1 (es) Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk
UY31278A1 (es) Nuevos derivados de n, n??-2,4-dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y especialmente como inhibidores de ikk
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
CU20110088A7 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
UY30642A1 (es) Nuevos derivados imidazolonas, su preparacion como medicamentos, composiciones farmaceuticas, utilizacion como inhibidores de proteinas quinasas principalmente cdc7
ECSP077167A (es) Nuevos compuestos heterociclicos
CR8270A (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170803